Latest Breaking News On - Pediatric hepatology - Page 1 : comparemela.com

Viral hepatitis is a public health problem in India requiring urgent attention, say doctors | Indiablooms

Faridabad: India has the world’s second-highest prevalence of viral hepatitis cases. While hepatitis A and E cause an acute form of the disease, hepatitis B and C lead to chronic liver disease including cirrhosis and even liver cancer.

Jammu and kashmirTamil naduHimachal pradeshBhaskar nandiWorld health organisationWorld liver dayAmrita hospitalGlobal hepatitis reportHepatitisb virusArunachal pradeshAndaman nicobar islandArti pawariaClinical leadSenior consultantPediatric hepatology

Mirum Pharmaceuticals Presents LIVMARLI Clinical Data and Real-World Evidence at NASPGHAN

Mirum Pharmaceuticals Presents LIVMARLI Clinical Data and Real-World Evidence at NASPGHAN
valdostadailytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from valdostadailytimes.com Daily Mail and Mail on Sunday newspapers.

United statesIntrahepatic cholestasisAndrew mckibbenErin murphyGerard odellPediatric hepatology researchHealth canadaExcellence in pediatric hepatology researchEuropean commissionDrug administrationMirum pharmaceuticals incPediatric hepatologyPam vigAlagille syndromeFamilial intrahepatic cholestasisGerard odell prize

Mirum Pharmaceuticals Presents LIVMARLI Clinical Data and Real-World Evidence at NASPGHAN

Mirum Pharmaceuticals Presents LIVMARLI Clinical Data and Real-World Evidence at NASPGHAN
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesErin murphyIntrahepatic cholestasisAndrew mckibbenSam martinGerard odellDrug administrationHealth canadaPediatric hepatology researchEuropean commissionExcellence in pediatric hepatology researchMirum pharmaceuticals incGerard odell prizePediatric hepatologyPam vigAlagille syndrome

Mirum Pharmaceuticals to Highlight LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual Meeting

Mirum Pharmaceuticals to Highlight LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoAndrew mckibbenSam martinIntrahepatic cholestasisErin murphyPediatric hepatology researchAmerican society for pediatric gastroenterologyMirum pharmaceuticals incGerard odell prizePediatric hepatologyNorth american societyPediatric gastroenterologyLiver diseaseAlagille syndromePoster session

Mirum Pharmaceuticals LIVMARLI (maralixibat) Approved by the European Commission for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome Two Months and Older

Mirum Pharmaceuticals’ LIVMARLI (maralixibat) Approved by the European Commission for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome Two Months and OlderDec 13, 2022- First and only medication approved in both the U.S. and Europe to treat cholestatic pruritus in patients with Alagille.

United statesFrance generalUnited kingdomSouth koreaGreat britainChris peetzEmmanuel jacqueminAle kremlinRoberta smithMirum pharmaceuticalsEuropean commissionDrug administrationAlagille syndrome allianceSaclay universityEuropean unionMirum pharmaceuticals inc